Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 146

1.

Benign versus malignant breast masses: optical differentiation with US-guided optical imaging reconstruction.

Zhu Q, Cronin EB, Currier AA, Vine HS, Huang M, Chen N, Xu C.

Radiology. 2005 Oct;237(1):57-66. Erratum in: Radiology. 2006 May;239(2):613.

2.

Early-stage invasive breast cancers: potential role of optical tomography with US localization in assisting diagnosis.

Zhu Q, Hegde PU, Ricci A Jr, Kane M, Cronin EB, Ardeshirpour Y, Xu C, Aguirre A, Kurtzman SH, Deckers PJ, Tannenbaum SH.

Radiology. 2010 Aug;256(2):367-78. doi: 10.1148/radiol.10091237. Epub 2010 Jun 22.

3.

Assessment of Functional Differences in Malignant and Benign Breast Lesions and Improvement of Diagnostic Accuracy by Using US-guided Diffuse Optical Tomography in Conjunction with Conventional US.

Zhu Q, Ricci A Jr, Hegde P, Kane M, Cronin E, Merkulov A, Xu Y, Tavakoli B, Tannenbaum S.

Radiology. 2016 Aug;280(2):387-97. doi: 10.1148/radiol.2016151097. Epub 2016 Mar 2.

PMID:
26937708
4.

Solid breast lesions: clinical experience with US-guided diffuse optical tomography combined with conventional US.

Zhi W, Gu X, Qin J, Yin P, Sheng X, Gao SP, Li Q.

Radiology. 2012 Nov;265(2):371-8. doi: 10.1148/radiol.12120086. Epub 2012 Sep 25.

PMID:
23012460
5.

US-guided diffused optical tomography: a promising functional imaging technique in breast lesions.

You SS, Jiang YX, Zhu QL, Liu JB, Zhang J, Dai Q, Liu H, Sun Q.

Eur Radiol. 2010 Feb;20(2):309-17. doi: 10.1007/s00330-009-1551-y. Epub 2009 Aug 26.

PMID:
19707770
6.

US-guided optical tomography: correlation with clinicopathologic variables in breast cancer.

Choi JS, Kim MJ, Youk JH, Moon HJ, Suh HJ, Kim EK.

Ultrasound Med Biol. 2013 Feb;39(2):233-40. doi: 10.1016/j.ultrasmedbio.2012.09.014. Epub 2012 Dec 4.

PMID:
23219038
7.

Supplemental use of optical diffusion breast imaging for differentiation between benign and malignant breast lesions.

Moon JH, Kim HH, Shin HJ, Kim H, Ko MS, Gong G.

AJR Am J Roentgenol. 2011 Sep;197(3):732-9. doi: 10.2214/AJR.10.5102.

PMID:
21862818
8.

Effect of vascular haemoglobin concentrations on ultrasound-guided diffuse optical tomography in differentiating benign from malignant breast lesions.

Lv N, He N, Wu Y, Xie C, Wang Y, Kong Y, Wei W, Wu P.

Eur Radiol. 2014 Nov;24(11):2848-56. doi: 10.1007/s00330-014-3356-x. Epub 2014 Aug 6.

PMID:
25097131
9.

Ultrasound-guided optical tomographic imaging of malignant and benign breast lesions: initial clinical results of 19 cases.

Zhu Q, Huang M, Chen N, Zarfos K, Jagjivan B, Kane M, Hedge P, Kurtzman SH.

Neoplasia. 2003 Sep-Oct;5(5):379-88.

10.

Solid breast masses: classification with computer-aided analysis of continuous US images obtained with probe compression.

Moon WK, Chang RF, Chen CJ, Chen DR, Chen WL.

Radiology. 2005 Aug;236(2):458-64.

PMID:
16040902
11.

US-guided diffuse optical tomography for breast lesions: the reliability of clinical experience.

Kim MJ, Kim JY, Youn JH, Kim MH, Koo HR, Kim SJ, Sohn YM, Moon HJ, Kim EK.

Eur Radiol. 2011 Jul;21(7):1353-63. doi: 10.1007/s00330-011-2060-3. Epub 2011 Jan 28.

PMID:
21274716
12.

Detecting angiogenesis in breast tumors: comparison of color Doppler flow imaging with ultrasound-guided diffuse optical tomography.

Zhu Q, You S, Jiang Y, Zhang J, Xiao M, Dai Q, Sun Q.

Ultrasound Med Biol. 2011 Jun;37(6):862-9. doi: 10.1016/j.ultrasmedbio.2011.03.010. Epub 2011 Apr 30.

PMID:
21531497
13.

Utilizing optical tomography with ultrasound localization to image heterogeneous hemoglobin distribution in large breast cancers.

Zhu Q, Kurtzma SH, Hegde P, Tannenbaum S, Kane M, Huang M, Chen NG, Jagjivan B, Zarfos K.

Neoplasia. 2005 Mar;7(3):263-70.

14.

Differentiating benign from malignant solid breast masses with US strain imaging.

Burnside ES, Hall TJ, Sommer AM, Hesley GK, Sisney GA, Svensson WE, Fine JP, Jiang J, Hangiandreou NJ.

Radiology. 2007 Nov;245(2):401-10.

PMID:
17940302
15.

Combined optical and X-ray tomosynthesis breast imaging.

Fang Q, Selb J, Carp SA, Boverman G, Miller EL, Brooks DH, Moore RH, Kopans DB, Boas DA.

Radiology. 2011 Jan;258(1):89-97. doi: 10.1148/radiol.10082176. Epub 2010 Nov 9.

16.

MR-Guided Near-Infrared Spectral Tomography Increases Diagnostic Performance of Breast MRI.

Mastanduno MA, Xu J, El-Ghussein F, Jiang S, Yin H, Zhao Y, Wang K, Ren F, Gui J, Pogue BW, Paulsen KD.

Clin Cancer Res. 2015 Sep 1;21(17):3906-12. doi: 10.1158/1078-0432.CCR-14-2546. Epub 2015 May 27.

17.

Distinguishing benign from malignant masses at breast US: combined US elastography and color doppler US--influence on radiologist accuracy.

Cho N, Jang M, Lyou CY, Park JS, Choi HY, Moon WK.

Radiology. 2012 Jan;262(1):80-90. doi: 10.1148/radiol.11110886. Epub 2011 Nov 14.

PMID:
22084209
18.

Phase-contrast diffuse optical tomography pilot results in the breast.

Liang X, Zhang Q, Li C, Grobmyer SR, Fajardo LL, Jiang H.

Acad Radiol. 2008 Jul;15(7):859-66. doi: 10.1016/j.acra.2008.01.028.

PMID:
18572121
19.

Optical tomography with ultrasound localization for breast cancer diagnosis and treatment monitoring.

Zhu Q, Tannenbaum S, Kurtzman SH.

Surg Oncol Clin N Am. 2007 Apr;16(2):307-21. Review.

20.

Near-infrared imaging of the breast using omocianine as a fluorescent dye: results of a placebo-controlled, clinical, multicenter trial.

Poellinger A, Persigehl T, Mahler M, Bahner M, Ponder SL, Diekmann F, Bremer C, Moesta T.

Invest Radiol. 2011 Nov;46(11):697-704. doi: 10.1097/RLI.0b013e318229ff25.

PMID:
21788905

Supplemental Content

Support Center